Form 4: Cardlytics Director Liane Hornsey Acquires 11,000 Restricted Stock Units

Director Liane Hornsey acquired 11,000 restricted stock units (RSUs) of Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date, provided she remains a director.

Summary

• On May 20, 2025, Liane Hornsey, a director of Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
• The RSUs will vest in full on the one-year anniversary of the grant date, provided that Ms. Hornsey remains a director of Cardlytics on that date.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock units granted to a director. It indicates confidence but doesn't provide specific financial insights.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest in one year, contingent on continued service as a director.

Industry Context

Form 4 filings are routine disclosures of insider transactions and provide transparency to the market.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Cardlytics, Director, Liane Hornsey, Restricted Stock Units, RSUs, Beneficial Ownership, Form 4, SEC Filing